Filter by
Medicinal products - Latest updates (242)
RSSAgenda - 102nd meeting of the Pharmaceutical Committee (1 April 2025)
Questions and Answers on the Critical Medicines Act
Commission proposes Critical Medicines Act to bolster the supply of critical medicines in the EU
Registration - EUHPP Live Webinar: Introducing the AUGMENT Biosimilars Project - Goals, learnings and next steps (18 March 2025, 11.00-12.00 CET)
Medicines for children 2023 annual report
Representatives of Patients' Associations and Clinicians: Reopening of the Call for expressions of interest for the EMA Committee for Advanced Therapies (EMA CAT)
Registration - Biosimilar medicines - Multistakeholder Event (5 December 2024)
Registration - Implementation of the Hospital Exemption in the EU and its role in boosting innovation and patient access to innovative therapies (21 November 2024)
Representatives of Patients' Associations and Clinicians: Call for expressions of interest is open for the EMA Committee for Advanced Therapies
Civil Society representatives: Call for expressions of interest is open for the EMA Management Board
Deadline extended to 30 September 2024 - Call for expressions of interest to appoint Representatives of Patients’ Organisations and Healthcare professionals for EMA PRAC
Questions and Answers Document – Regulation (EU) 536/2014 – Version 6.9, July 2024
Civil Society representatives: Call for expressions of interest is open for the EMA Management Board
Representatives of Patients' Associations and Clinicians: Call for expressions of interest is open for the EMA Committee for Advanced Therapies
Independent Scientific experts: Call for expressions of interest for the EMA PRAC Committee
The amendments of the Variation Regulation are published in the Official Journal of the European Union
Agenda and registration - Consultation conference: EU guidance on public procurement of medicines (23 May 2024)
Global Gateway: European Commission and Belgian Presidency increase their support to the African Medicines Agency
Commission proposes new measures for the better lifecycle management of medicine authorisations
Factsheet - Access to medicines in all Member States